Recommendations for the management of gastrointestinal comorbidities with or without trofinetide use in Rett syndrome

Abstract excerpt

INTRODUCTION: gene, many neurologists and pediatricians do not rank the management of these comorbidities among the most important treatment goals for RTT. Trofinetide, the first approved pharmacologic treatment for RTT, confers improvements in RTT symptoms but is associated with adverse GI events, primarily diarrhea and vomiting. Treatment strategies for GI comorbidities and drug-associated symptoms in RTT...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Child Nutrition and Feeding Issues
• Share to Family and Disability Support Research
• Share to Genetics and Neurodevelopmental Disorders